GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Total Inventories

ANTCF (Aion Therapeutic) Total Inventories : $0.42 Mil (As of Oct. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Total Inventories?

Aion Therapeutic's total inventories for the quarter that ended in Oct. 2024 was $0.42 Mil. Aion Therapeutic's average total inventories from the quarter that ended in Jul. 2024 to the quarter that ended in Oct. 2024 was $0.40 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Aion Therapeutic's Net-Net Working Capital per share for the quarter that ended in Oct. 2024 was $-0.01.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aion Therapeutic's Days Inventory for the three months ended in Oct. 2024 was 250.78.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aion Therapeutic's Inventory Turnover for the quarter that ended in Oct. 2024 was 0.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aion Therapeutic's Inventory-to-Revenue for the quarter that ended in Oct. 2024 was 1.60.


Aion Therapeutic Total Inventories Historical Data

The historical data trend for Aion Therapeutic's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Total Inventories Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Total Inventories
Get a 7-Day Free Trial - - - - 0.30

Aion Therapeutic Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.30 0.30 0.38 0.42

Aion Therapeutic Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Aion Therapeutic  (OTCPK:ANTCF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Aion Therapeutic's Net-Net Working Capital Per Share for the quarter that ended in Oct. 2024 is

Net-Net Working Capital Per Share (Q: Oct. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.068+0.75 * 0.08+0.5 * 0.424-4.106
-0-0)/497.149
=-0.01

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aion Therapeutic's Days Inventory for the three months ended in Oct. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Oct. 2024 )/Cost of Goods Sold (Q: Oct. 2024 )*Days in Period
=0.404/0.147*365 / 4
=250.78

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aion Therapeutic's Inventory Turnover for the quarter that ended in Oct. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Oct. 2024 ) / Average Total Inventories (Q: Oct. 2024 )
=0.147 / 0.404
=0.36

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aion Therapeutic's Inventory to Revenue for the quarter that ended in Oct. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Oct. 2024 ) / Revenue (Q: Oct. 2024 )
=0.404 / 0.253
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Aion Therapeutic Total Inventories Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.